1 |
ADRB2
| 9件: Calcium signaling pathway Calcium signaling pathway 💬, cGMP-PKG signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Adrenergic signaling in cardiomyocytes 💬, Regulation of lipolysis in adipocytes 💬, Renin secretion 💬, Salivary secretion 💬, Chemical carcinogenesis - receptor activation 💬 | D02147
D02147
|
Salbutamol
| 14件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 |
2 |
ABAT
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, Valine, leucine and isoleucine degradation 💬, beta-Alanine metabolism 💬, Propanoate metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
3 |
GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
4 |
GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
5 |
GABRA1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
6 |
GABRA2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
7 |
GABRA2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
8 |
GABRA2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
9 |
GABRA3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
10 |
GABRA3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
11 |
GABRA3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
12 |
GABRA4
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
13 |
GABRA4
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
14 |
GABRA4
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
15 |
GABRA5
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
16 |
GABRA5
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
17 |
GABRA5
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
18 |
GABRA6
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
19 |
GABRA6
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
20 |
GABRA6
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Taste transduction 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
21 |
GABRB1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
22 |
GABRB1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
23 |
GABRB1
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
24 |
GABRB2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
25 |
GABRB2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
26 |
GABRB2
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
27 |
GABRB3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
28 |
GABRB3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
29 |
GABRB3
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
30 |
GABRD
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
31 |
GABRD
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
32 |
GABRD
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
33 |
GABRE
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
34 |
GABRE
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
35 |
GABRE
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
36 |
GABRG1
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
37 |
GABRG1
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
38 |
GABRG1
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
39 |
GABRG2
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
40 |
GABRG2
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
41 |
GABRG2
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
42 |
GABRG3
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
43 |
GABRG3
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
44 |
GABRG3
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
45 |
GABRP
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
46 |
GABRP
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
47 |
GABRP
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
48 |
GAD1
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, beta-Alanine metabolism 💬, Taurine and hypotaurine metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬, Type I diabetes mellitus 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
49 |
GAD2
| 7件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, beta-Alanine metabolism 💬, Taurine and hypotaurine metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬, GABAergic synapse 💬, Type I diabetes mellitus 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
50 |
MSTN
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | D11797
D11797
|
Apitegromab
| 1件: 3 3 |
51 |
GHR
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬, Neuroactive ligand-receptor interaction 💬, PI3K-Akt signaling pathway 💬, JAK-STAT signaling pathway 💬, Growth hormone synthesis, secretion and action 💬 | D02691
D02691
|
Somatotropin
| 23件: 2 2, 3, 13, 19, 46, 65, 74, 75, 76, 78, 96, 107, 113, 187, 191, 193, 195, 236, 238, 265, 274, 276, 299 |
52 |
GNRHR
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, GnRH signaling pathway 💬 | D00989
D00989
|
Leuprolide
| 5件: 1 1, 2, 3, 51, 76 |
53 |
GRIA1
| 14件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
54 |
GRIA2
| 15件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
55 |
GRIA3
| 13件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Long-term depression 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Transcriptional misregulation in cancer 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
56 |
GRIA4
| 10件: cAMP signaling pathway cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Retrograde endocannabinoid signaling 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Huntington disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Amphetamine addiction 💬, Nicotine addiction 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
57 |
GRIK1
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
58 |
GRIK2
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
59 |
GRIK3
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
60 |
GRIK4
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
61 |
GRIK5
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Glutamatergic synapse 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
62 |
GRIN1
| 18件: Ras signaling pathway Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Alcoholism 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
63 |
GRIN2A
| 19件: Ras signaling pathway Ras signaling pathway 💬, Rap1 signaling pathway 💬, Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Spinocerebellar ataxia 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Alcoholism 💬, Systemic lupus erythematosus 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
64 |
GRIN2B
| 19件: Ras signaling pathway Ras signaling pathway 💬, Rap1 signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Dopaminergic synapse 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Huntington disease 💬, Spinocerebellar ataxia 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Alcoholism 💬, Systemic lupus erythematosus 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
65 |
GRIN2C
| 15件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Spinocerebellar ataxia 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Alcoholism 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
66 |
GRIN2D
| 15件: Calcium signaling pathway Calcium signaling pathway 💬, cAMP signaling pathway 💬, Neuroactive ligand-receptor interaction 💬, Circadian entrainment 💬, Long-term potentiation 💬, Glutamatergic synapse 💬, Alzheimer disease 💬, Amyotrophic lateral sclerosis 💬, Spinocerebellar ataxia 💬, Prion disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Cocaine addiction 💬, Amphetamine addiction 💬, Nicotine addiction 💬, Alcoholism 💬 | D00775
D00775
|
Riluzole
| 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
67 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00472
D00472
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
68 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00980
D00980
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
69 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00981
D00981
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
70 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D00982
D00982
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
71 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01239
D01239
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
72 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D01998
D01998
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
73 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D02156
D02156
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
74 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | D03301
D03301
|
Prednisolone
| 43件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
75 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D00075
D00075
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
76 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D00957
D00957
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
77 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D00958
D00958
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
78 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D00959
D00959
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
79 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D06085
D06085
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
80 |
AR
| 4件: Oocyte meiosis Oocyte meiosis 💬, Pathways in cancer 💬, Chemical carcinogenesis - receptor activation 💬, Prostate cancer 💬 | D06087
D06087
|
Testosterone
| 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
81 |
KCNA4
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion 💬, Cushing syndrome 💬 | D04127
D04127
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 |
82 |
KCNA4
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion 💬, Cushing syndrome 💬 | D10228
D10228
|
Amifampridine
| 3件: 3 3, 11, 12 |
83 |
KCNC3
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia 💬 | D04127
D04127
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 |
84 |
KCNC3
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia 💬 | D10228
D10228
|
Amifampridine
| 3件: 3 3, 11, 12 |
85 |
KCND2
| 1件: Serotonergic synapse Serotonergic synapse 💬 | D04127
D04127
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 |
86 |
KCND2
| 1件: Serotonergic synapse Serotonergic synapse 💬 | D10228
D10228
|
Amifampridine
| 3件: 3 3, 11, 12 |
87 |
KCND3
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia 💬 | D04127
D04127
|
Dalfampridine
| 5件: 3 3, 4, 6, 13, 14 |
88 |
KCND3
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia 💬 | D10228
D10228
|
Amifampridine
| 3件: 3 3, 11, 12 |
89 |
ACHE
| 2件: Glycerophospholipid metabolism Glycerophospholipid metabolism 💬, Cholinergic synapse 💬 | D00487
D00487
|
Pyridostigmine
| 4件: 3 3, 6, 11, 256 |
90 |
GABRQ
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00550
D00550
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
91 |
GABRQ
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D00696
D00696
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
92 |
GABRQ
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬, Retrograde endocannabinoid signaling 💬, GABAergic synapse 💬, Morphine addiction 💬, Nicotine addiction 💬 | D05028
D05028
|
Midazolam
| 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
93 |
PTGS1
| 5件: Arachidonic acid metabolism Arachidonic acid metabolism 💬, Metabolic pathways 💬, Platelet activation 💬, Serotonergic synapse 💬, Regulation of lipolysis in adipocytes 💬 | D00217
D00217
|
Acetaminophen
| 18件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
94 |
PTGS2
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism 💬, Metabolic pathways 💬, NF-kappa B signaling pathway 💬, VEGF signaling pathway 💬, C-type lectin receptor signaling pathway 💬, IL-17 signaling pathway 💬, TNF signaling pathway 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, Ovarian steroidogenesis 💬, Oxytocin signaling pathway 💬, Regulation of lipolysis in adipocytes 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Leishmaniasis 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Pathways in cancer 💬, Chemical carcinogenesis - DNA adducts 💬, MicroRNAs in cancer 💬, Small cell lung cancer 💬 | D00217
D00217
|
Acetaminophen
| 18件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
95 |
PTGS2
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism 💬, Metabolic pathways 💬, NF-kappa B signaling pathway 💬, VEGF signaling pathway 💬, C-type lectin receptor signaling pathway 💬, IL-17 signaling pathway 💬, TNF signaling pathway 💬, Retrograde endocannabinoid signaling 💬, Serotonergic synapse 💬, Ovarian steroidogenesis 💬, Oxytocin signaling pathway 💬, Regulation of lipolysis in adipocytes 💬, Alzheimer disease 💬, Pathways of neurodegeneration - multiple diseases 💬, Leishmaniasis 💬, Human cytomegalovirus infection 💬, Human papillomavirus infection 💬, Kaposi sarcoma-associated herpesvirus infection 💬, Pathways in cancer 💬, Chemical carcinogenesis - DNA adducts 💬, MicroRNAs in cancer 💬, Small cell lung cancer 💬 | D00567
D00567
|
Celecoxib
| 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
96 |
RRM2
| 6件: Purine metabolism Purine metabolism 💬, Pyrimidine metabolism 💬, Glutathione metabolism 💬, Drug metabolism - other enzymes 💬, Metabolic pathways 💬, p53 signaling pathway 💬 | D00341
D00341
|
Hydroxyurea
| 8件: 3 3, 13, 19, 20, 65, 85, 86, 284 |
97 |
SMN2
| 1件: Nucleocytoplasmic transport Nucleocytoplasmic transport 💬 | D11406
D11406
|
Risdiplam
| 1件: 3 3 |
98 |
TNNC2
| 1件: Calcium signaling pathway Calcium signaling pathway 💬 | D11363
D11363
|
Reldesemtiv
| 1件: 3 3 |
99 |
ALDH5A1
| 3件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism 💬, Butanoate metabolism 💬, Metabolic pathways 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
100 |
CACNA1I
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
101 |
CACNA1H
| 7件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |
102 |
CACNA1G
| 8件: MAPK signaling pathway MAPK signaling pathway 💬, Calcium signaling pathway 💬, Circadian entrainment 💬, Aldosterone synthesis and secretion 💬, Cortisol synthesis and secretion 💬, GnRH secretion 💬, Type II diabetes mellitus 💬, Cushing syndrome 💬 | D00399
D00399
|
Valproic acid
| 17件: 2 2, 3, 5, 6, 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 |